US Age-related Macular Degeneration Market and Competitive Landscape Highlights - 2016

  • ID: 3679723
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Age-related Macular Degeneration Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Age-related Macular Degeneration pipeline products, Age-related Macular Degeneration epidemiology, Age-related Macular Degeneration market valuations and forecast, Age-related Macular Degeneration products sales and competitive landscape in the US.

The research is classified into nine sections – Age-related Macular Degeneration overview including etiology, pathophysiology, and diagnosis, Age-related Macular Degeneration treatment options, Age-related Macular Degeneration pipeline products, Age-related Macular Degeneration market analysis comprising of Age-related Macular Degeneration epidemiology, key products marketed for Age-related Macular Degeneration, market valuations and forecast, products sales and market shares.

Research Scope:
- Age-related Macular Degeneration Pipeline: Find out the products in clinical trials for the treatment of Age-related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Age-related Macular Degeneration Epidemiology: Find out the number of patients diagnosed (prevalence) with Age-related Macular Degeneration in the US
- Age-related Macular Degeneration Products: Identify key products marketed and prescribed for Age-related Macular Degeneration in the US, including trade name, molecule name, and company
- Age-related Macular Degeneration Product Sales: Find out the sales revenues of Age-related Macular Degeneration products, both branded and generics, in the US
- Age-related Macular Degeneration Market Valuations: Find out the market size for Age-related Macular Degeneration products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Age-related Macular Degeneration Products Market Share: Find out the market shares for key Age-related Macular Degeneration products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Age-related Macular Degeneration market analysis and sales trends
- Track competitor drugs sales and market share in the US Age-related Macular Degeneration market
- Track competitive developments in Age-related Macular Degeneration market and present key issues and learnings
- Synthesize insights for Age-related Macular Degeneration market and products to drive business performance
- Answer key business questions about the Age-related Macular Degeneration market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Age-related Macular Degeneration products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Age-related Macular Degeneration Treatments
3) Age-related Macular Degeneration Pipeline
4) US Age-related Macular Degeneration Epidemiology
5) Marketed Drugs for Age-related Macular Degeneration in US
6) US Age-related Macular Degeneration Market Size
7) US Age-related Macular Degeneration Products Sales
8) US Age-related Macular Degeneration Market Competitive Landscape
9) US Age-related Macular Degeneration Market Forecast
10) Methodology
11) Contact us

1. Age-related Macular Degeneration Epidemiology, US, 2010 - 2020
2. Age-related Macular Degeneration Market Size ($), US, 2010 – 2015
3. Age-related Macular Degeneration Products Market Share (%), US, 2015
4. Age-related Macular Degeneration Market Forecast ($), US, 2015 – 2020

1. Age-related Macular Degeneration Phase 3 Clinical Trials, 2016
2. Age-related Macular Degeneration Phase 2 Clinical Trials, 2016
3. Age-related Macular Degeneration Phase 1 Clinical Trials, 2016
4. Age-related Macular Degeneration Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Age-related Macular Degeneration, US, 2016
6. Age-related Macular Degeneration Market Size ($), US, 2010 – 2015
7. Age-related Macular Degeneration Product Sales ($), US, 2010 – 2015
8. Age-related Macular Degeneration Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll